Filing Flows › Elevance Health (ELV) › Q3 2026
Elevance Health (ELV) Q3 2026 earnings results (third quarter 2026)
10-Q filed Oct 21, 2026
Elevance Health (ELV) reported revenue of $51.4B for the third quarter 2026 (Q3 2026), +1% from a year earlier and +2% from the quarter before. Operating margin was 2.5%, net earnings $1.3B (2.6% of revenue).
Elevance Health, Q3 2026: revenue $51.4B (+1% year over year), operating margin 2.5%, net earnings $1.3B, operating cash flow $1.3B. The chart follows the revenue to costs, profit and cash.
| Q3 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $51.4B | +2% | +1% |
| Operating profit | $1.3B | -28% | -2% |
| Net earnings | $1.3B | -8% | +13% |
| Operating cash flow | $1.3B | -34% | +12% |
| Free cash flow | $1.0B | -38% | +29% |
What changed
Revenue was $51.4B in Q3 2026, up 1% year over year and up 2% from the previous quarter.
Operating profit was $1.3B, a 2.5% margin (down 0.1 points year over year). Operating profit fell $0.03B even though revenue rose $0.72B versus Q3 2025, so costs grew faster than sales. Total costs grew 2% against revenue growth of 1%. Net earnings were $1.4B, up 15% year over year. The effective tax rate was 25.1%. Non-operating items added $0.53B, 29% of pre-tax earnings, so the bottom line overstates operating performance.
Operating cash flow was $1.3B (up 12% year over year), 94% of net earnings. Non-cash charges added back $0.36B of depreciation and amortization and $0.08B of share-based compensation. Working capital and other items used $0.52B. Capital expenditures of $0.27B left free cash flow of $1.0B.
Questions
What was Elevance Health's revenue in the third quarter 2026?
Elevance Health (ELV) reported revenue of $51.4B for the third quarter 2026 (Q3 2026), +1% from a year earlier and +2% from the quarter before.
Was Elevance Health profitable in the third quarter 2026?
Operating profit was $1.3B (2.5% of revenue) and net earnings $1.3B.
Source: Elevance Health 10-Q on SEC EDGAR.